✦ LIBER ✦

Randomized, controlled trial with interferon-α (IFN-α) combined with ribavirin with and without amantadinsulfat in primary IFN-α non-responders with chronic hepatitis C

✍ Scribed by Teuber, Gerlinde; Berg, Thomas; Lafrenz, Manfred; Weidenbach, Hans; Schoelmerich, Juergen; Wietzke-Braun, Perdita; Pausch, Juergen; Arnold, Rudolf; Lock, Guntram; Udo, Hopf; Zeuzem, Stefan

Book ID: 124140180
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 176 KB
Volume: 120
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(08)81894-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, controlled trial with IFN-α

Randomized, controlled trial with IFN-α combined with ribavirin with and without amantadine sulphate in non-responders with chronic hepatitis C

✍ Gerlinde Teuber; M Pascu; T Berg; M Lafrenz; J Pausch; F Kullmann; G Ramadori; R 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Randomized, controlled trial with interf

Randomized, controlled trial with interferon-alpha (IFN-alpha) combined with ribavirin with and without amantadine sulfate in primary IFN-alpha nonresponsive patients with chronic hepatitis C

✍ G. Teuber; T. Berg; M. Lafrenz; H. Weidenbach; J. Schoelmerich; P. Wietzke-Braun 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Natural alfa-interferon (nα-IFN) therapy

Natural alfa-interferon (nα-IFN) therapy in patients with chronic hepatitis C non-responders to recombinant alfa-interferon (rα-IFN)

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Randomized, controlled pilot trial of in

Randomized, controlled pilot trial of interferonα (IFN) with or without thymosinα1 (TA1) in naive chronic hepatitis C (CHC)

✍ A. Gramenzi; L. Di Giammarino; C. Cursaro; F. Felline; S. Talarico; A. D'Errico; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Interferon-α2bInduction Treatment with o

Interferon-α2bInduction Treatment with or Without Ribavirin in Chronic Hepatitis C: A Multicenter, Randomized, Controlled Trial

✍ Hakan Senturk; Galip Ersoz; Resat Ozaras; Sabahattin Kaymakoglu; Hakan Bozkaya; 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 389 KB

Interferon-α (IFN) induction dosing and

Interferon-α (IFN) induction dosing and ribavirin (R) in IFN non-responders (NR) with chronic hepatitis C (CHC): Interim analysis of an ongoing study (SASL 10)

✍ E.C. Renner-Schneiter; J-F. Dufour; R. Fried; J.J. Gonvers; M. Knoblauch; P.J. M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 153 KB